Our specialty pharmaceuticals, branded generics and consumer products play a role in helping millions of people live healthier lives and providing treatment to those affected by debilitating diseases. We remain committed to improving the health and well-being of people everywhere, profitably growing our businesses, and bringing value to our shareholders.

Stock Performance

Recent Events

Barclays Global Healthcare Conference

03/15/17

Q4 and FY2016 Earnings Results and 2017 Guidance

02/28/17

RBC 2017 Healthcare Conference

02/23/17

General Investor Relations
Elif McDonald
Director, Investor Relations
Email: ir@valeant.com
877-281-6642
514-856-3855 (Canada)